Despite technical advances in coronary artery bypass grafting (CABG),

Size: px
Start display at page:

Download "Despite technical advances in coronary artery bypass grafting (CABG),"

Transcription

1 Early Detection and Control of Perioperative Ischemia After Coronary Artery Bypass Grafting Mohamed M. Abdel Aal MD* Ahmad A. AlShaer MD ** * Division of Cardiac Surgery, **Division of Anesthesia, Heart Sciences Department, King Fahad Cardiac Center, College of Medicine at King Saud University Riyadh, Kingdom of Saudi Arabia. malaal2@hotmail.com Codex : o4/24/1111 Background: Despite technical advances in coronary artery bypass grafting (CABG), early postoperative myocardial ischemia still remains a challenging problem. The aim of this study was to determine the clinical features, and management of early graft failure in the present CABG era. Methods: 670 patients underwent CABG at our institution between January 2007 and January Twelve patients out of them had ECG changes and biochemical criteria for myocardial ischemia. Post-operative myocardial ischemia was suspected if the following criteria were present: New changes in the ST- segment in the ECG, rise of biochemical enzymes, recurrent or sustained ventricular tachyarrhythmia, ventricular fibrillation (VF), hemodynamic deterioration and left ventricular failure. Patients with severe hemodynamic instability were rushed to the operating room. Results: 670 Patients underwent CABG; twelve patients out of them (1.79%) were identified as suspected of having post-operative ischemia or infarction. The median age was 63 years (range: years). The median time between the primary and re-operation was 9 hours. Nine patients (75%) out of twelve had circulatory collapse in the intensive care unit and were rushed to the operating room (OR), four of them with repeated ventricular fibrillation (VF) and five with new severe ST-changes with elevated creatine kinase (CK/CK-MB) value above 10%. Three patients (25%) out of twelve developed circulatory collapse after sternal closure. The angiography was done in two patients. Acute vein thrombosis were found in eight patients (66.6%) as well as incorrect anastomosis in two patients (16.6%) and stretched graft in one patient each (8.3%). In one patient no evident cause for their severely impaired hemodynamic status was found. There was one patient in-hospital death. Conclusion: Early graft failure generally presents with ST segment change and elevation of CK/CK-MB ratio. Graft occlusion or thrombosis is the leading cause of ischemia. Patients with circulatory collapse could be saved by an immediate reoperation without preceding angiography with low risk. Keywords: Coronary graft failure, coronary angiography, post-cabg. Despite technical advances in coronary artery bypass grafting (CABG), early postoperative complications are still associated with a significant in-hospital morbidity and mortality. Perioperative myocardial infarction (PMI) is one of the major complications after CABG. 1 Early ischemia or infarction after CABG is based upon different graft-related and non-graft-related mechanisms. Early graft failure like graft occlusion, graft kinking, overstretching, subtotal anastomotic stenosis, or graft spasm is the most common graft-related reasons for early ischemia after CABG. Graft occlusion can be caused by thrombosis due to poor quality of the graft or recipient artery, by technical deficiencies related to the newly inserted graft, or by the size of the native coronary artery. 2 The early detection of post-operative ischemia is important for optimal patient management to prevent in-hospital mortality. Early re-intervention like coronary artery stenting or immediate reoperation even in case of early graft failure may salvage or limit myocardial damage, thus improving patient outcome. 3 Clinical presentation of early graft failure is dominated by postoperative myocardial ischemia could be a result of a spasm, left ventricular dysfunction, life-threatening ventricular arrhythmias and 152 Journal of The Egyptian Society of Cardio-Thoracic Surgery Jul - Dec 2011

2 hemodynamics instability. Localized ST changes indicate a high probability of graft failure and especially in combination with high levels of creatine kinase (CK-MB) isoenzyme.4 Although cardiac isoforms of troponins, are supposed to be more specific and sensitive as indicators of myocardial necrosis than conventional cardiac enzymes like creatine kinase (CK) particularly in the postoperative period after cardiac surgery, the identification of patients with PMI induced by early graft failure remains unclear. 5 Coronary angiography remains the gold standard for assessment of graft patency, but this invasive procedure is not routinely performed after CABG. Coronary angiography has proven to be safe and precise to confirm early graft failure. 6 Our intentions with this study were to determine the incidence, clinical features and to identify early post-operative ischemia, visualize the cause and start treatment before permanent myocardial damage occurred in patients who underwent CABG. Patients & Methods Between January 2007 and January 2010, 670 patients were identified from the our database underwent isolated CABG at the Department of Cardiac Surgery in King Fahad cardiac center, Riyadh, Saudi Arabia. Twelve patients (1.79%) out of them developed signs of early post-operative ischemia. Operative Procedures Anesthesia was standardized in all patients. Left internal mammary artery (LIMA) and saphenous vein grafts were used as graft conduits in all patients. Proximal graft anastomoses to the aorta were performed with partial occlusion of the ascending aorta. Heparin was administered in order to achieve an activated coagulation time above 400 seconds. Standard cardiopulmonary bypass (CPB) technique was used with ascending aortic and two-stage venous cannulation. Myocardial protection was achieved using antegrade warm blood cardioplegic arrest and single aortic cross clamping for all distal anastomosis. Intra-operative graft flow measurement (Cardiomed, MediStim, Oslo, Norway) was routinely applied after CPB just before sternal closure under stable hemodynamic conditions for each graft. Postoperative Management: Postoperative management was standardized; patients were monitored with arterial pressure, pulmonary pressure, and central venous pressure immediately after the arrival on the intensive care unit. A 12-lead electrocardiogram (ECG) was obtained and repeated at least four times within the first 24 hours (hrs) and once every 24 hrs till patient discharge. CK and CK-MB values were obtained and analyzed immediately after surgery and six hourly during the first 24 hrs post-operatively,then 12 hourly in the second post-operative day and once daily for next 3 days post-operatively. Aspirin therapy restarted within the first post-operative while heparin administered intravenously (IV) after 24 hrs of surgery provided there is no significant bleeding. Hospital death was defined as death occurring during the first 30 days after CABG. Myocardial ischemia suspected if: (a) increase in the isoenzyme ratio of CK/CK-MB above 10%, (b) ischemic electrocardiographic episodes (new onset of elevated ST-segment change which were verified with the use of the ECG monitor print out (ECG complexes) and a 12 leads electrocardiogram., (c) recurrent episodes of, or sustained ventricular tachyarrhythmia as well as ventricular fibrillation, (d) hemodynamic deterioration and left ventricular failure despite maximum inotropic support. A diagnostic repeat angiography was performed in two patients who were more stable postoperatively. All unsatisfactory grafts were substituted, when possible with new graft material. If the graft was thrombosed, the thrombotic material has to be removed and the vessel rinsed for possible reuse. LIMA can be re-used if a good flow can be established. If a small caliber of LIMA was suspected to be a possible cause of ischemia, a vein graft was added. The incision in the coronary artery was extended to facilitate and improve the new anastomosis. Inotropic drugs, intra-aortic balloon pump (IABP) or left ventricular assist device (VAD) were used when required to wean the patient from cardiopulmonary bypass. Statistical analysis Baseline characteristics and other categorical variables are presented as median, mean ± standard deviation, or as percentage of total patients. Results 670 patients underwent CABG; twelve of them (1.79%) were identified as suspected of having post-operative ischemia or infarction and managed as described above. There were 2 females and 10 males with a median age of 63 years (range: years). The median number of grafts per patient was three. LIMA was used in 11 patients (91.6%). The median aortic cross-clamp time 58±12 minutes. The indications for emergency re-operation in this study were: 1. New changes in the ST-segment, 2. CK/CK-MB value above 10%, 3. Sustained VT or repeated VF, 4. Hemodynamic deterioration due to left ventricular failure. The median time between the primary and re-operation was 9 hours. Nine patients (75%) had circulatory collapse in the intensive care unit and were rushed to the OR with ongoing resuscitation, four of them with repeated VF and five with new severe ST-changes and elevated CK/CK-MB value above 10%.Three patients (25%) out of twelve developed circulatory collapse after sternal closure but before leaving the OR. Journal of The Egyptian Society of Cardio-Thoracic Surgery Volume 19, Number (3-4) 153

3 The angiography was done in two patients, showed graft failure because LIMA dissection and acute vein graft thrombosis. Data are summarized in table 1. No. of Patients % New ST change CK/CKMB > 10% Sustained arrhythmia Hemodynamic deterioration 3 25 Table 1: Indications for re-revascularization. CK: creatine kinase During re-operation, graft occlusions due to acute vein thrombosis were found in eight patients (66.6%) as well as incorrect anastomosis in two patients (16.6%) and one patient (8.3%) with stretched graft. One patient had no evident cause for severely impaired hemodynamic status (table 2). No. of patients % Graft occlusion Incorrect anastomosis Stretched graft No finding Table 2: Intra-operative findings. Most of the patients were weaned without problems from CPB with assistance of IABP which was inserted during re-operation in ten patients; two of them additionally required a temporary extracorporal membrane oxygenation (ECMO) and ventricular assisted device (VAD) (table 3). There was one patient in-hospital death (8.3%) due to severe left ventricular failure. Characteristics No. of patients % LIMA % IABP VAD ECMO Table 3: Procedure-related variables. Data are presented as median (range) or (%). LIMA; left internal mammary artery, IABP: intra-aortic balloon pulsation, VAD: ventricular assisted device and ECMO: extra-corporal membrane oxygenation. Discussion The detection and interpretation of perioperative myocardial ischemia following coronary bypass grafting still remains a challenging problem for the clinician. Graft failure is a constant finding in patients with circulatory collapse early after a CABG and survival after immediate re-operation is possible. 7 The diagnostic criteria to identify patients suspected of early myocardial ischemia or infarction after CABG surgery is more difficult to interpret and less specific than in un-operated patients. ECG changes, especially ST-elevation appearing in many or all leads, have been a recurrent matter of discussion; is it ischemia or post-operative pericarditis? The CPB, manipulation with the heart during surgery and possible suboptimal cardioplegia may also lead to elevated CK-MB values immediately after surgery 8. Clinical presentation of early graft failure is dominated by post-operative myocardial ischemia, left ventricular dysfunction, life-threatening ventricular arrhythmias and hemodynamic instability. Procedure related factors affecting myocardial protection such as hypothermia, type and application of cardioplegia and manipulation of the heart during on pump beating or off pump CABG techniques, may all lead to reperfusion injury and significant rise of CK-MB values 9. In the present study, localized ST-changes followed by an elevation of the CK/CK-MB ratio above 10% and ventricular arrhythmias were the predominant clinical presentation. Fabricus and associates 9 have reported a high mortality rate, ranging from 14.5% to 21.7% with substantial rate of nonfatal complications while Steuer and coworkers 10 reported 1.9% with early deaths in their study. Our hospital mortality was 8.3%, the cause of death was severe left ventricular dysfunction. Previous studies have reported that the incidence of perioperative ischemia is 8 to 35 % in patients undergoing CABG. 11 The lower incidence of early post-operative ischemia in our study (1.79%) is perhaps related to small volume and the presence of a lower risk population in our study. Thielmann and associates 12 demonstrated in their study that the incidence of early graft failure within 24 hrs after CABG is about 1 3%, leading to early post-operative myocardial ischemia and irreversible myocardial cell damage, strongly associated with a higher mortality within 30 days and a higher incidence of major adverse events. However, they mentioned that, the possible benefit of an emergency re-revascularization procedure like percutaneous coronary intervention (PCI) or a reoperation in their clinical setting of myocardial ischemia and its time-dependency is currently unknown. To date, there are no guidelines clearly clarifying this issue. Although, the exact time point of graft failure and the onset of symptoms mostly remain uncertain in the early postoperative course, recent clinical trials have been hypothesized and demonstrated that even delayed reperfusion of infarcted 154 Journal of The Egyptian Society of Cardio-Thoracic Surgery Jul - Dec 2011

4 myocardium may be beneficial by reducing myocardial infarct size, improving myocardial healing and preventing electrical instability 13. Holmvang and coworkers 14 found that the majority of patients presenting with myocardial ischemia after CABG had either graft failure, or incomplete or even inadequate revascularization demonstrated by repeat angiography. Their prospective study confirms that early (within 7 days) graft occlusion is not uncommon, occurring in 8% of vein grafts and 2% of IMA conduits. These occlusion rates are in accordance with previous findings. Importantly, these early graft occlusions are potentially detectable because they are associated with a rise in serum concentration of biochemical markers of infarction. In our study, ST-segment deviation and T-wave changes with rise in serum concentration of biochemical markers of infarction were usually associated with the independent predictor of acute ischemia. ECG, clinical presentation and serial postoperative biochemical data can identify the patients with early graft occlusion after CABG. Interpretation of the ECG data is not conclusive because pericardial involvement and change in heart position might cause ECG changes without concomitant graft occlusion. Some of the limitations associated with the ECG data might be solved if reliable continuous ECG ischemia monitoring in multiple leads could be performed in the ICU. A review by Califf and associates 15 recommend preprocedural and post-procedural ECGs combined with serial measurements of CK-MB for identification of patients with procedure-related myocardial infarction. However, the published consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction 16 points out the difficulties in diagnosing PMI defined as myocardial damage due to coronary artery occlusion, because myocardial damage can be caused by different mechanisms, including direct trauma during the surgical procedure. Nevertheless, the consensus report states that the higher the value for the cardiac biomarker, the greater the amount of damage to the myocardium, irrespective of the mechanism. Our study has limitations The primary limitation of this study is that it is a single centre and analysis of a small group of patients. Thus, our results may not be generalized to other centers. The indication for re-cabg, or conservative treatment was not prospectively defined, but the decision for a secondary revascularization strategy was made case by case. Therefore, the present study may contain a study bias. Clinical implications The feasibility and safety of re-revascularization following CABG at an early stage should encourage cardiac surgeons and cardiologists to implement collaborative efforts when signs of graft failure occur. In conclusion We found that the combination of ST segment change and elevation of CK/CK-MB ratio is highly effective in detecting early graft failure. Patients with graft failure can be re-operated with a low risk, if the patient is hemodynamically stable. Patients with circulatory collapse could be saved by an immediate re- operation without preceding angiography. References 1. Virani SS, Alam M, Mendoza CE, Arora H, Ferreira AC, de Marchena E. Clinical significance, angiographic characteristics, and short-term outcomes in 30 patients with early coronary artery graft failure. Neth Heart J January; 17(1): Thielmann M, Massoudy P, Schmermund A, Neuhauser M, Marggraf G, Kamler K, Herold U, Aleksic I, Mann K, Haude M, Heusch G, Erbel R, Jakob H. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J 2005;26: Lip, GY, Metcalfe, MJ. Have we identified the factors affecting prognosis following coronary artery bypass surgery? Br J Clin Pract 1994;48, Douglas JS. Percutaneous intervention in patients with prior coronary bypass surgery. In Topol EH (ed): Textbook of Interventional Cardiology. Philadelphia. W.B. Saunders Company, 1999, Fellahi J-L, Gue X, Richomme X, Monnier E, Guillon L, Riou B. Short- and long-term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 2003;99: Onorati F, De Feo M, Mastroroberto P, Cristodoro L, Pezzo F, Renzulli A, Cotrufo M. Determinants and prognosis of myocardial damage after coronary artery bypass grafting. Ann Thorac Surg 2005;79: Thielmann M, Massoudy P, Marggraf G, Knipp S, Schmermund A, Piotrowski J, Erbel R, Jakob H. Role of troponin I, myoglobin, and creatine kinase for the detection of early graft failure following coronary artery bypass grafting. Eur J Cardiothorac Surg 2004;26: Rasmussen C, Thiis JJ, Clemmensen P, Efsen F, Arendrup HC, Saunamäki K, Madsen JK, Pettersson G. Significance and management of early graft failure after coronary artery bypass grafting: feasibility and results of acute angiography and re-revascularization. Eur J Cardiothorac Surg 1997;12: Farbicius AM, Gerbes W, Hanke M, Garbade J, Autschbach R, Mohr F. Early angiographic control of perioperative ischemia after coronary artery bypass grafting. EurJ Cardiothorac Surg 2001;19: Steuer J, Horte LG, Lindahl B, Stahle E. Impact of perioperative myocardial injury on early and long-term Journal of The Egyptian Society of Cardio-Thoracic Surgery Volume 19, Number (3-4) 155

5 outcome after coronary artery bypass grafting Eur Heart J 2002;23: Simon C, Capuano F, Roscitano A, Benedetto U, Comito C, Sinatra R. Cardiac Troponin I vs EuroSCORE: Myocardial Infarction and Hospital Mortality Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): Thielmann M, Massoudy P, Jaeger BR, Neuhäuser M, Marggraf G, Sack S, Erbel R and Jakob H. Emergency rerevascularization with percutaneous coronary intervention, reoperation, or conservative treatment in patients with acute perioperative graft failure following coronary artery bypass surgery. Eur J Cardiothorac Surg 2006;30: Scho mig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F, Nekolla SG, Schlotterbeck K, Schuhlen H, Pache J, Seyfarth M, Martinoff S, Benzer W, Schmitt C, Dirschinger J, Schwaiger M, Kastrati A. Beyond Alternative Evaluation (BRAVE-2) Trial Investigators. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. J Am Med Assoc 2005;293: Holmvang L, Jurlander B, Rasmussen C, Thiis JJ, Grande P, Clemmensen P. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. Chest 2002;121: Califf, RM, Abdelmeguid, AE, Kuntz RE, Pompa J.J., Davidson C.J., Cohen E.A., Kleiman N.S., Mahaffey K.W., Topol E.J., Pepine C.J., Lipicky R.J., Granger C.B., Harrington R.A., Tardiff B.E., Crenshaw B.S., Bauman R.P., Zuckerman B.D., Chaitman B.R., Bittl J.A., Ohman E.M. Myonecrosis after revascularization procedures. J Am Coll Cardiol 1998;31, The joint European Society of Cardiology/American College of Cardiology committee Myocardial infarction redefined a consensus document of the joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: Journal of The Egyptian Society of Cardio-Thoracic Surgery Jul - Dec 2011

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital

More information

Heart Center Packages

Heart Center Packages Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com

More information

Utilizing the Cath Lab for Cardiac Arrest

Utilizing the Cath Lab for Cardiac Arrest Utilizing the Cath Lab for Cardiac Arrest Khaled M. Ziada, MD Director, Cardiovascular Catheterization Laboratories Gill Heart Institute, University of Kentucky UK/AHA Strive to Revive Symposium May 2013

More information

The Cardiac Society of Australia and New Zealand

The Cardiac Society of Australia and New Zealand The Cardiac Society of Australia and New Zealand Guidelines on Support Facilities for Coronary Angiography and Percutaneous Coronary Intervention (PCI) including Guidelines on the Performance of Procedures

More information

Duration of Dual Antiplatelet Therapy After Coronary Stenting

Duration of Dual Antiplatelet Therapy After Coronary Stenting Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are

More information

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize

More information

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head

ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY. Dr. Mahesh Vakamudi. Professor and Head ANESTHESIA FOR PATIENTS WITH CORONARY STENTS FOR NON CARDIAC SURGERY Dr. Mahesh Vakamudi Professor and Head Department of Anesthesiology, Critical Care and Pain Medicine Sri Ramachandra University INTRODUCTION

More information

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology Objectives Acute Coronary Syndromes Epidemiology and Health Care Impact Pathophysiology Unstable Angina NSTEMI STEMI Clinical Clues Pre-hospital Spokane County EMS Epidemiology About 600,000 people die

More information

California Health and Safety Code, Section 1256.01

California Health and Safety Code, Section 1256.01 California Health and Safety Code, Section 1256.01 1256.01. (a) The Elective Percutaneous Coronary Intervention (PCI) Pilot Program is hereby established in the department. The purpose of the pilot program

More information

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators

PRECOMBAT Trial. Seung-Whan Lee, MD, PhD On behalf of the PRECOMBAT Investigators Premier of Randomized Comparison of Bypass Surgery versus Angioplasty Using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease PRECOMBAT Trial Seung-Whan Lee, MD, PhD On behalf

More information

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease

Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,

More information

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter

Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter Endoskopische Venenentnahme (EVH) - Einführung 1979 Tevaearai und Kollegen haben

More information

ANESTHESIA FOR MYOCARDIAL REVASCULARIZATION. Alla Klimova, M.D UAMS, Little Rock, AR

ANESTHESIA FOR MYOCARDIAL REVASCULARIZATION. Alla Klimova, M.D UAMS, Little Rock, AR ANESTHESIA FOR MYOCARDIAL REVASCULARIZATION Alla Klimova, M.D UAMS, Little Rock, AR Objectives Historical perspective of CABG Stent or surgery Indication for CABG surgery On pump CABG : design and pathophysiology

More information

Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009

Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009 Cardiac Catheterization Curriculum for Fellows in Cardiology Dartmouth-Hitchcock Medical Center Level 1 and Level 2 Training 2008-2009 I. Overview of Training in Cardiac Catheterization Cardiac catheterization

More information

Thoracoabdominal aortic aneurysm

Thoracoabdominal aortic aneurysm Thoracoabdominal aortic aneurysm Patient (1) - 69 PMH: 2013 - MVP, aortic root replacement with biological valve (Perimount) and subtotal aortic arch replacement Analysis for oppressive chest complaints

More information

The return of myocardial ischemia after coronary artery

The return of myocardial ischemia after coronary artery Occurrence and Risk Factors for Reintervention After Coronary Artery Bypass Grafting Joseph F. Sabik III, MD; Eugene H. Blackstone, MD; A. Marc Gillinov, MD; Nicholas G. Smedira, MD; Bruce W. Lytle, MD

More information

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications

More information

Management of Pacing Wires After Cardiac Surgery

Management of Pacing Wires After Cardiac Surgery Management of Pacing Wires After Cardiac Surgery David E. Lizotte, Jr. PA C, MPAS, FAPACVS President, Association of Physician Assistants in Cardiovascular Surgery Conflicts: None Indications 2008 Journal

More information

The Bioresorbable Vascular Stent Dr Albert Ko

The Bioresorbable Vascular Stent Dr Albert Ko The Bioresorbable Vascular Stent Dr Albert Ko Dr Albert Ko MB BS, FRACP, FCSANZ Interventional/General Cardiologist Ascot Cardiology Symposium 2013 Treatment Goals for Coronary Artery Disease Relieve of

More information

In the current era of stent usage, before patients with multivessel disease are finally

In the current era of stent usage, before patients with multivessel disease are finally Does prior percutaneous coronary angioplasty and/or stenting adversely affect early outcome after coronary artery bypass Surgery? Ahmed Rezk MD,* Adel Almasswary MD** Ali Youssef MD** Objectives: Percutaneous

More information

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013. Reference: NHSCB/A09/PS/b Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy Statement: Percutaneous

More information

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO

REFERRAL HOSPITAL. The Importance of Door In Door Out Time DIDO REFERRAL HOSPITAL The Importance of Door In Door Out Time DIDO Time to Treatment is critical for STEMI patients For patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary

More information

Appendix. Costing Case Samples for OOHCA

Appendix. Costing Case Samples for OOHCA Appendix Costing Case Samples for OOHCA The patient (ICD-1) Treatment Codes (OPCS 4) Patient 27 Admitted to ICU following percutaneous cardiac intervention (PCI) with 2 drugeluting stents following a VF

More information

Perioperative Cardiac Evaluation

Perioperative Cardiac Evaluation Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project

More information

Your Guide to Express Critical Illness Insurance Definitions

Your Guide to Express Critical Illness Insurance Definitions Your Guide to Express Critical Illness Insurance Definitions Your Guide to EXPRESS Critical Illness Insurance Definitions This guide to critical illness definitions will help you understand the illnesses

More information

Cilostazol versus Clopidogrel after Coronary Stenting

Cilostazol versus Clopidogrel after Coronary Stenting Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background

More information

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY

BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY BASIC STANDARDS FOR RESIDENCY TRAINING IN CARDIOLOGY American Osteopathic Association and the American College of Osteopathic Internists Specific Requirements For Osteopathic Subspecialty Training In Cardiology

More information

CARDIAC RISKS OF NON CARDIAC SURGERY

CARDIAC RISKS OF NON CARDIAC SURGERY CARDIAC RISKS OF NON CARDIAC SURGERY N E W S T U D I E S & N E W G U I D E L I N E S W. B. C A L H O U N, M D, F A C C 2014 ACC/AHA Guideline on perioperative cardiovascular evaluation and management

More information

ECG may be indicated for patients with cardiovascular risk factors

ECG may be indicated for patients with cardiovascular risk factors eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,

More information

Emergency Management Strategies for Acute Myocardial Infarction - Code R at LGH

Emergency Management Strategies for Acute Myocardial Infarction - Code R at LGH Emergency Management Strategies for Acute Myocardial Infarction - Code R at LGH PAUL N. CASALE, M.D., F.A.C.C. Chief, Division of Cardiology and Medical Director of Cardiology, Lancaster General Hospital

More information

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,

More information

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty

Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor

More information

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto

Resuscitation in congenital heart disease. Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto Resuscitation in congenital heart disease Peter C. Laussen MBBS FCICM Department Critical Care Medicine Hospital for Sick Children Toronto Evolution of Congenital Heart Disease Extraordinary success: Overall

More information

Graft Flow Increases with Release of Stabilizing Device in Off-pump Coronary Surgery

Graft Flow Increases with Release of Stabilizing Device in Off-pump Coronary Surgery Original Article Graft Flow Increases with Release of Stabilizing Device in Off-pump Coronary Surgery Alistair G. Royse, MDBS, FRACS, 1,2 Colin F. Royse, MDBS, FANZCA, 1,3 and Christina T. Wong 1 Transit-time

More information

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs

A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory

More information

Electrocardiographic Body Surface Mapping

Electrocardiographic Body Surface Mapping Electrocardiographic Body Surface Mapping Policy Number: 2.02.23 Last Review: 4/2016 Origination: 10/2009 Next Review: 10/2016 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will not provide

More information

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD

CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ. Charles White MD CORONARY ARTERY BYPASS GRAFTS, STENTS, AND EXTRACORONARY CARDIAC DZ Charles White MD Director of Thoracic Imaging Department of Radiology University of Maryland CORONARY ARTERY BYPASS GRAFTS First performed

More information

DIAGNOSTIC CRITERIA OF AMI/ACS

DIAGNOSTIC CRITERIA OF AMI/ACS DIAGNOSTIC CRITERIA OF AMI/ACS Diagnostic criteria are used to validate clinical diagnoses. Those used in epidemiological studies are here below reported. 1. MONICA - Monitoring trends and determinants

More information

Diagnostic and Therapeutic Procedures

Diagnostic and Therapeutic Procedures Diagnostic and Therapeutic Procedures Diagnostic and therapeutic cardiovascular s are central to the evaluation and management of patients with cardiovascular disease. Consistent with the other sections,

More information

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Recommendations of the European Society of Cardiology Updated version December 2002 Task Force on management

More information

Determinants of duration of ICU stay after coronary artery bypass graft surgery

Determinants of duration of ICU stay after coronary artery bypass graft surgery British Journal of Anaesthesia 1996; 77: 208 212 Determinants of duration of ICU stay after coronary artery bypass graft surgery A. MICHALOPOULOS, G. TZELEPIS, G. PAVLIDES, J. KRIARAS, U. DAFNI AND S.

More information

Addendum to Clinical Review for NDA 22-512

Addendum to Clinical Review for NDA 22-512 Addendum to Clinical Review for DA 22-512 Drug: Sponsor: Indication: Division: Reviewers: dabigatran (Pradaxa) Boehringer Ingelheim Prevention of stroke and systemic embolism in atrial fibrillation Division

More information

Liau DW : Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis. ASA Newsletter 70(6): 11-13 & 16, 2006.

Liau DW : Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis. ASA Newsletter 70(6): 11-13 & 16, 2006. Citation Liau DW : Injuries and Liability Related to Peripheral Catheters: A Closed Claims Analysis. ASA Newsletter 70(6): 11-13 & 16, 2006. Full Text An anesthesiologist inserted a 14-gauge peripheral

More information

The left internal mammary artery (LIMA) is the

The left internal mammary artery (LIMA) is the Case Report 925 Direct Stenting of a Transradial Left Internal Mammary Artery Graft Wei-Chin Hung, MD; Bih-Fang Guo, MD, PhD; Chiung-Jen Wu, MD; Chien-Jen Chen, MD; Chih-Yuan Fang, MD Taking the transfemoral

More information

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease

Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease Cardiac Rehabilitation An Underutilized Class I Treatment for Cardiovascular Disease What is Cardiac Rehabilitation? Cardiac rehabilitation is a comprehensive exercise, education, and behavior modification

More information

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care

Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care Measure #257 (NQF 1519): Statin Therapy at Discharge after Lower Extremity Bypass (LEB) National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

More information

Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS

Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES GENERAL PROVISIONS Ch. 138 CARDIAC CATHETERIZATION SERVICES 28 138.1 CHAPTER 138. CARDIAC CATHETERIZATION SERVICES Sec. 138.1 Principle. 138.2. Definitions. GENERAL PROVISIONS PROGRAM, SERVICE, PERSONNEL AND AGREEMENT REQUIREMENTS

More information

Redefining the NSTEACS pathway in London

Redefining the NSTEACS pathway in London Redefining the NSTEACS pathway in London Sotiris Antoniou Consultant Pharmacist, Cardiovascular Medicine, Barts and The London NHS Trust and Project Lead, North East London Cardiovascular and Stroke Network

More information

Prognostic impact of uric acid in patients with stable coronary artery disease

Prognostic impact of uric acid in patients with stable coronary artery disease Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,

More information

Aktuelle Literatur aus der Notfallmedizin

Aktuelle Literatur aus der Notfallmedizin 05.02.2014 Aktuelle Literatur aus der Notfallmedizin prä- und innerklinisch Aktuelle Publikationen aus 2012 / 2013 PubMed hits zu emergency medicine 12,599 Abstract OBJECTIVES: Current American Heart

More information

Complications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005

Complications of Femoral Catheterization. Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005 Complications of Femoral Catheterization Daniel Kaufman, MD University Hospital of Brooklyn December 16, 2005 Case Presentation xx yr old female presents with fever, chills, and painful swelling of R groin

More information

INSTEAD at 5-year follow-up shifts the expectations for endovascular treatment

INSTEAD at 5-year follow-up shifts the expectations for endovascular treatment INSTEAD at 5-year follow-up shifts the expectations for endovascular treatment Christoph A. Nienaber, MD, FACC University Heart Center Rostock Department of Medicine I - Cardiology christoph.nienaber@med.uni-rostock.de

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine

Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics. Yen Tibayan, M.D. Division of Cardiovascular Medicine Is it really so? : Varying Presentations for ACS among Elderly, Women and Diabetics Yen Tibayan, M.D. Division of Cardiovascular Medicine Case Presentation 69 y.o. woman calls 911 with the complaint of

More information

Reporting Transcatheter Aortic Valve Replacement (TAVR) Procedures in 2013

Reporting Transcatheter Aortic Valve Replacement (TAVR) Procedures in 2013 Reporting Transcatheter Aortic Valve Replacement (TAVR) Procedures in 2013 There are nine new CPT codes effective January 1, 2013, for reporting TAVR procedures. Five of these codes are Category I codes

More information

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.

More information

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach

Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach Endovascular Repair of an Axillary Artery Aneurysm: A Novel Approach Bao- Thuy D. Hoang, MD 1, Jonathan- Hien Vu, MD 2, Jerry Matteo, MD 3 1 Department of Surgery, University of Florida College of Medicine,

More information

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014

CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from

More information

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements

Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Atrial Fibrillation in the ICU: Attempting to defend 4 controversial statements Salmaan Kanji, Pharm.D. The Ottawa Hospital The Ottawa Hospital Research Institute Conflict of Interest No financial, proprietary

More information

Surgeons Role in Atrial Fibrillation

Surgeons Role in Atrial Fibrillation Atrial Fibrillation Surgeons Role in Atrial Fibrillation Steven J Feldhaus, MD, FACS 2015 Cardiac Symposium September 18, 2015 Stages of Atrial Fibrillation Paroxysmal (Intermittent) Persistent (Continuous)

More information

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology

Specific Basic Standards for Osteopathic Fellowship Training in Cardiology Specific Basic Standards for Osteopathic Fellowship Training in Cardiology American Osteopathic Association and American College of Osteopathic Internists BOT 07/2006 Rev. BOT 03/2009 Rev. BOT 07/2011

More information

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38

The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38 Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac

More information

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG

More information

Lifecheque Basic Critical Illness Insurance

Lifecheque Basic Critical Illness Insurance Lifecheque Basic Critical Illness Insurance Strong. Reliable. Trustworthy. Forward-thinking. Extra help on the road to recovery Surviving a critical illness can be very challenging financially Few of us

More information

Denominator Statement: Cardiac surgery patients with no evidence of prior infection.

Denominator Statement: Cardiac surgery patients with no evidence of prior infection. Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)

More information

Interactive Cardiovascular and Thoracic Surgery 1 (2002) 30 34. Institutional review

Interactive Cardiovascular and Thoracic Surgery 1 (2002) 30 34. Institutional review Interactive Cardiovascular and Thoracic Surgery 1 (2002) 30 34 Institutional review Totally endoscopic coronary artery bypass grafting on the arrested heart is a prerequisite for successful totally endoscopic

More information

Automatic External Defibrillators

Automatic External Defibrillators Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth

More information

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate

More information

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,

More information

12 Lead ECGs: Ischemia, Injury & Infarction Part 2

12 Lead ECGs: Ischemia, Injury & Infarction Part 2 12 Lead ECGs: Ischemia, Injury & Infarction Part 2 McHenry Western Lake County EMS Localization: Left Coronary Artery Right Coronary Artery Right Ventricle Septal Wall Anterior Descending Artery Left Main

More information

PREOPERATIVE CARDIAC RISK FOR NONCARDIAC SURGERY Review of 2014 ACC/AHA Guidelines and Implications for Clinical Care

PREOPERATIVE CARDIAC RISK FOR NONCARDIAC SURGERY Review of 2014 ACC/AHA Guidelines and Implications for Clinical Care PREOPERATIVE CARDIAC RISK FOR NONCARDIAC SURGERY Review of 2014 ACC/AHA Guidelines and Implications for Clinical Care Ronald L Walsh, D.O., MACOI, FACC ACOI Clinical Challenges in Inpatient Care March

More information

Policies and Procedures. Related to. IABP Therapy

Policies and Procedures. Related to. IABP Therapy Policies and Procedures Related to IABP Therapy Courtesy of Datascope Corp. Clinical Support Services The following policies and procedures are intended to serve as guidelines for developing hospital policy.

More information

Ischemia and Infarction

Ischemia and Infarction Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to

More information

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark

Copenhagen University Hospital Rigshospitalet Aarhus University Hospital Skejby Denmark Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-elevation myocardial infarction 3 year follow-up of the randomised trial Peter Clemmensen, Henning Kelbæk,

More information

06 Validation of risk prediction model

06 Validation of risk prediction model HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via

More information

Electrocardiographic Issues in Williams Syndrome

Electrocardiographic Issues in Williams Syndrome Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital

More information

URN: Family name: Given name(s): Address:

URN: Family name: Given name(s): Address: State of Queensland (Queensland Health) 2015 Licensed under: http://creativecommons.org/licenses/by-nc-nd/3.0/au/deed.en Contact: Clinical_Pathways_Program@health.qld.gov.au Facility:... Clinical pathways

More information

Clinical Practice Assessment Robotic surgery

Clinical Practice Assessment Robotic surgery Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through

More information

Medical Tourism - The Role of Intervals inCardiovascular Cancer

Medical Tourism - The Role of Intervals inCardiovascular Cancer Acute Decompensated Heart Failure: Time Critical Interventions MO-51 / 1 Hour Faculty: Matthew Strehlow, MD, FACEP Monday, 10/26/2015 / 3:30 PM - 4:20 PM The treatment of congestive heart failure (CHF)

More information

Podcast with Dr. Kossick

Podcast with Dr. Kossick Podcast with Dr. Kossick Interviewed by Western Carolina University Graduate Anesthesia Student Kristin Andrejco From the Head of the Bed main@fromtheheadofthebed.com December 5, 2014 (33 min) EKG Lead

More information

Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC

Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC The Federal Motor Carrier Safety Administration (FMCSA) administers the Federal Motor Carrier Safety Regulations (FMCSRs)

More information

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)

CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart

More information

Perfusion Downunder Collaboration Database Data Quality Assurance: Towards a High Quality Clinical Database

Perfusion Downunder Collaboration Database Data Quality Assurance: Towards a High Quality Clinical Database The Journal of ExtraCorporeal Technology Perfusion Downunder Collaboration Database Data Quality Assurance: Towards a High Quality Clinical Database Sigrid C. Tuble, PhD, CCRC Department of Cardiac and

More information

Mortality Risk Conferred by Small Elevations of Creatine Kinase-MB Isoenzyme After Percutaneous Coronary Intervention

Mortality Risk Conferred by Small Elevations of Creatine Kinase-MB Isoenzyme After Percutaneous Coronary Intervention Journal of the American College of Cardiology Vol. 42, No. 8, 2003 2003 by the American College of Cardiology Foundation ISSN 0735-1097/03/$30.00 Published by Elsevier Inc. doi:10.1016/s0735-1097(03)01044-1

More information

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania

DUAL ANTIPLATELET THERAPY. Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY Dr Robert S Mvungi, MD(Dar), Mmed (Wits) FCP(SA), Cert.Cardio(SA) Phy Tanzania Cardiac Society Dar es Salaam Tanzania DUAL ANTIPLATELET THERAPY (DAPT) Dual antiplatelet regimen

More information

SIGN 93 Acute coronary syndromes. A national clinical guideline Updated February 2013

SIGN 93 Acute coronary syndromes. A national clinical guideline Updated February 2013 Help us to improve SIGN guidelines - click here to complete our survey SIGN 93 Acute coronary syndromes A national clinical guideline Updated February 2013 Evidence KEY TO EVIDENCE STATEMENTS AND GRADES

More information

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES

DATE: 29 August 2012 CONTEXT AND POLICY ISSUES TITLE: Dual Antiplatelet Therapy and Enoxaparin or Unfractionated Heparin for patients with ST-elevation Myocardial Infarction: A Review of the Clinical Evidence DATE: 29 August 2012 CONTEXT AND POLICY

More information

European Heart Journal (1999) 20, 1014 1019 Article No. euhj.1998.1395, available online at http://www.idealibrary.com on

European Heart Journal (1999) 20, 1014 1019 Article No. euhj.1998.1395, available online at http://www.idealibrary.com on European Heart Journal (1999) 20, 1014 1019 Article No. euhj.1998.1395, available online at http://www.idealibrary.com on Working Group Report Indications for intracoronary stent placement: the European

More information

Coding Updates for 2013: Cardiology

Coding Updates for 2013: Cardiology Coding Updates for 2013: Cardiology Presented by: David Dunn, MD, FACS CIRCC, CPC-H, CCVTC, CCC, CCS, RCC National Coding Standards Sources of information Centers for Medicare and Medicare (CMS) Provider

More information

Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo

Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo Marco Ferlini Struttura Semplice di Emodinamica, UO Cardiologia Dipartimento Cardiotoracovascolare Fondazione IRCCS, Policlinico San Matteo Acute Coronary Syndromes: oral antithrombotic therapy Focus on

More information

Tips and Tricks to Demystify 12 Lead ECG Interpretation

Tips and Tricks to Demystify 12 Lead ECG Interpretation Tips and Tricks to Demystify 12 Lead ECG Interpretation Mission: Lifeline North Dakota Regional EMS and Hospital Conference Samantha Kapphahn, DO Essentia Health- Interventional Cardiology June 5th, 2014

More information

Patients with end-stage renal disease (ESRD) are at high

Patients with end-stage renal disease (ESRD) are at high Long-Term Outcome of Renal Transplant Recipients in the United States After Coronary Revascularization Procedures Charles A. Herzog, MD; Jennie Z. Ma, PhD; Allan J. Collins, MD Background Retrospective

More information

REPORT OF A PILOT STUDY OF CMS. Objectives. We evaluated a telephone-based Care Management System (CMS) designed to

REPORT OF A PILOT STUDY OF CMS. Objectives. We evaluated a telephone-based Care Management System (CMS) designed to REPORT OF A PILOT STUDY OF CMS Page 1 Objectives. We evaluated a telephone-based Care Management System (CMS) designed to streamline the care for 30 pts previously hospitalized with ACS. Background. Many

More information

B etween 30% and 50% of patients with acute myocardial

B etween 30% and 50% of patients with acute myocardial 330 ORIGINAL ARTICLE Rescue percutaneous coronary intervention for failed thrombolysis: results from a district general hospital K P Balachandran, J Miller, ACHPell, B D Vallance, K G Oldroyd... Postgrad

More information

Mission: Lifeline Recommendations for Criteria for STEMI Systems of Care

Mission: Lifeline Recommendations for Criteria for STEMI Systems of Care Mission: Lifeline Recommendations for Criteria for STEMI Systems of Care The Mission: Lifeline Certification Program will acknowledge STEMI Systems, EMS, Non-PCI/STEMI Referral Centers and PCI/STEMI Receiving

More information

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

Stent for Life Initiative How can we improve system delay and patients delay in STEMI Stent for Life Initiative How can we improve system delay and patients delay in STEMI Z. Kaifoszova SFL Initiative Europe 2011 Stent for Life Initiative 10 countries participate in the program Declaration

More information

The Independent Order Of Foresters ( Foresters ) Critical Illness Rider (Accelerated Death Benefit) Disclosure at the Time of Application

The Independent Order Of Foresters ( Foresters ) Critical Illness Rider (Accelerated Death Benefit) Disclosure at the Time of Application The Independent Order of Foresters ( Foresters ) - A Fraternal Benefit Society. 789 Don Mills Road, Toronto, Canada M3C 1T9 U.S. Mailing Address: P.O. Box 179 Buffalo, NY 14201-0179 T. 800 828 1540 foresters.com

More information

Common Surgical Procedures in the Elderly

Common Surgical Procedures in the Elderly Common Surgical Procedures in the Elderly From hip and knee replacements to cataract and heart surgery, America s elderly undergo 20% of all surgical procedures. For a group that comprises only 13% of

More information

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies

Tranexamic Acid. Tranexamic Acid. Overview. Blood Conservation Strategies. Blood Conservation Strategies. Blood Conservation Strategies Overview Where We Use It And Why Andreas Antoniou, M.D., M.Sc. Department of Anesthesia and Perioperative Medicine University of Western Ontario November 14 th, 2009 Hemostasis Fibrinolysis Aprotinin and

More information